本页面由Tiger Trade Technology Pte. Ltd.提供服务

VBI Vaccines, Inc. (CDA)

0.0005
0.0000
成交量:- -
成交额:- -
市值:1.43万
市盈率:0.00
高:0.0005
开:0.0005
低:0.0005
收:0.0005
52周最高:0.0005
52周最低:0.0005
股本:2,868.23万
流通股本:2,673.45万
量比:0.31
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-4.2957
每股收益(LYR):-6.0261
净资产收益率:-419.59%
总资产收益率:-29.15%
市净率:-0.00
市盈率(LYR):0.00

数据加载中...

2025/01/03

重要事件披露

Form 8-K - Current report
2025/01/03

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/01/03

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/01/03

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/01/03

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/01/03

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/12/11

重要事件披露

Form 8-K - Current report
2024/09/06

交易所摘牌声明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2024/08/02

重要事件披露

Form 8-K - Current report
2024/07/30

重要事件披露

Form 8-K - Current report
2024/06/25

重要事件披露

Form 8-K - Current report
2024/05/29

重要事件披露

Form 8-K - Current report
2024/05/24

重要事件披露

Form 8-K - Current report
2024/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/15

重要事件披露

Form 8-K - Current report
2024/05/01

重要事件披露

Form 8-K - Current report
2024/04/17

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/04/16

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/04/16

重要事件披露

Form 8-K - Current report
2024/04/11

重要事件披露

Form 8-K - Current report